Ultrasound-guided Injections for de Quervain’s Tenosynovitis

McDermott, James D.; Ilyas, Asif M.; Nazarian, Levon N.; Leinberry, Charles F.

doi:10.1007/s11999-012-2369-5

Cited by 97 publications

(91 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…McDermott JD et al, reported in 2012 that at a follow up of 6 weeks, no complications were noted and 36 of the 37 wrist (97%). However 14% of wrist had recurrence of symptoms [17] This is in contrast to our study where 2 patients had recurrence of symptoms which relieved with another injection of Triamcinolone acetonide. Mohsin Mardani Kivi et al [22] conducted a prospective study over 67 patients.…”

Section: Discussioncontrasting

confidence: 95%

The efficacy of local steroid injection versus conservative management in Dequervain’s disease: A prospective randomised study

Ashok¹,

Js²,

Mittal³

et al. 2018

Int. J. Orthop. Sci.

View full text Add to dashboard Cite

De Quervain's tenosynovitis is a painful condition of the wrist which leads to difficulties in performing activities of daily living. Aim of the study is to examine the effectiveness of steroid injection therapy as compared to splinting and analgesics for treatment of de Quervain's tenosynovitis in adults. In (Group 1) the conservative group, patients were advised a splint and NSAIDS. In (Group 2) steroid group, patients were given injection of triamcinolone mixed with 2% xylocaine into the sheath of the affected tendons, under aseptic conditions. We found that steroid injection group showed 83.33% excellent results compared to only 36.67% in conservative group. We conclude that steroid injection is an effective form of conservative management for de Quervain's disease.

show abstract

Section: Discussioncontrasting

confidence: 95%

The efficacy of local steroid injection versus conservative management in Dequervain’s disease: A prospective randomised study

Ashok¹,

Js²,

Mittal³

et al. 2018

Int. J. Orthop. Sci.

View full text Add to dashboard Cite

show abstract

“…Retrospective and prospective cohort studies report improvements in most patients, but often over long time periods [6,11,16].…”

Section: Discussionmentioning

confidence: 99%

Disability and Pain after Cortisone versus Placebo Injection for Trapeziometacarpal Arthrosis and De Quervain Syndrome

Makarawung

Becker

Bekkers

et al. 2013

Hand (New York, N,Y.)

View full text Add to dashboard Cite

Background This study tested the null hypothesis that type of injection (corticosteroid vs. placebo) is not a predictor of arm-specific disability as measured with the Disabilities of Arm, Shoulder and Hand questionnaire 1 to 3 months after injection of dexamethasone or placebo for treatment of trapeziometacarpal (TMC) arthrosis or de Quervain syndrome. Secondly, we tested if type of injection was a predictor of pain intensity. Methods Thirty-six English-speaking adults with TMC arthrosis or de Quervain syndrome were randomized for a dexamethasone or a placebo injection. At time of the injection, patients completed a demographic data sheet and validated questionnaires assessing arm-specific disability, pain intensity, depressive symptoms, pain catastrophizing, and patient's health-related beliefs. At an average of 1.4 ± 0.42 months (range, 0.79-2.5 months) after the injection, patients completed questionnaires regarding arm-specific disability, pain, and treatment satisfaction. Grip and pinch strength measurements were measured at both time points. Bivariable and multivariable analyses assessed predictors of arm-specific disability and pain intensity at follow-up. Results Type of injection was not a predictor of arm-specific disability or pain intensity 1 to 3 months after injection. The best model both for arm-specific disability and pain intensity at follow-up included pain catastrophizing and explained 18 % and 33 % of the variability, respectively. Conclusions Catastrophic thinking was a better predictor of both of arm-specific disability and pain intensity than diagnosis or type of injection (steroid vs. placebo) 1to 3 months after an injection.

show abstract

“…The emergence of these new treatments, combined with the needle tenotomy techniques, have been made possible by the ability to visualize the degenerative tendon, perform percutaneous needling of the tendon and accurately place the injectate into the desired area. While [79] Acromioclavicular joint [80] Glenohumeral joint [81] Biceps tendon sheath [13] Aspiration/lavage of calcific tendinitis [68] Elbow Medial and lateral epicondyle [82] Elbow joint [83] Hand/wrist Carpal tunnel [84] De Quervain's tenosynovitis [85] Carpometacarpal and trapeziometacarpal joint [86] Trigger finger [87] Scaphotrapeziotrapezoid joint [88] Distal radioulnar joint [89] Lower extremity…”

Section: Musculoskeletal Medicinementioning

confidence: 99%

Musculoskeletal Ultrasound in Physical Medicine and Rehabilitation

Deimel

Jelsing

Hall

2013

Curr Phys Med Rehabil Rep

View full text Add to dashboard Cite

show abstract

Ultrasound-guided Injections for de Quervain’s Tenosynovitis

Abstract: We found ultrasound-guided injections to be useful for treatment of de Quervain's tenosynovitis. Our success with ultrasound-guided injections was slightly better than that reported in the literature and without adverse reactions.

Cited by 97 publications

References 31 publications

The efficacy of local steroid injection versus conservative management in Dequervain’s disease: A prospective randomised study

The efficacy of local steroid injection versus conservative management in Dequervain’s disease: A prospective randomised study

Disability and Pain after Cortisone versus Placebo Injection for Trapeziometacarpal Arthrosis and De Quervain Syndrome

Musculoskeletal Ultrasound in Physical Medicine and Rehabilitation

Contact Info

Product

Resources

About